• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子磁共振波谱在帕金森病黑质代谢物中的应用。

Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease.

机构信息

Department of Radiology, Second Xiangya Hospital, Central South University, 139 Renmin Road, Changsha, Hunan, 410011, People's Republic of China.

出版信息

Brain Imaging Behav. 2014 Mar;8(1):97-101. doi: 10.1007/s11682-013-9251-2.

DOI:10.1007/s11682-013-9251-2
PMID:23955491
Abstract

This study investigates changes in substantia nigra metabolites in Parkinson's disease (PD) using proton magnetic resonance spectroscopy ((1)H- MRS). Thirty patients with asymmetric PD and 20 normal controls were included in this study. Substantia nigra metabolites were detected in all subjects using 3D-multimer (1)H-MRS with a 3.0 T MRI scanner. The relative ratios of NAA/Cr, NAA/Cho, NAA/(Cho + Cr) in the substantia nigra were compared between two sides of asymmetric PD patients as well as between PD patients and controls. Significant differences in NAA/Cr, NAA/Cho, NAA/(Cho + Cr) were observed between PD patients and healthy controls (P < 0.05) as well as between the ipsilateral and contralateral of affected extremity in PD patients (P < 0.05). Significant differences in NAA/Cr, NAA/Cho, NAA/(Cho + Cr) were also observed between patients with mild and severe PD. Thus, we found that (1)H-MRS can be used to detect substantia nigra metabolites in PD patients, which may be useful for early diagnosis and evaluation of PD.

摘要

本研究采用质子磁共振波谱(1H-MRS)研究帕金森病(PD)患者黑质代谢物的变化。本研究纳入 30 例不对称性 PD 患者和 20 名正常对照者。所有受试者均使用 3.0T MRI 扫描仪进行 3D 多体(1H-MRS)检测黑质代谢物。比较了不对称性 PD 患者两侧以及 PD 患者与对照组之间黑质 NAA/Cr、NAA/Cho、NAA/(Cho+Cr)的相对比值。PD 患者与健康对照组之间(P<0.05)以及 PD 患者患侧与健侧之间(P<0.05)的 NAA/Cr、NAA/Cho、NAA/(Cho+Cr)均有显著差异。轻中度 PD 患者之间的 NAA/Cr、NAA/Cho、NAA/(Cho+Cr)也有显著差异。因此,我们发现 1H-MRS 可用于检测 PD 患者的黑质代谢物,这可能有助于 PD 的早期诊断和评估。

相似文献

1
Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease.质子磁共振波谱在帕金森病黑质代谢物中的应用。
Brain Imaging Behav. 2014 Mar;8(1):97-101. doi: 10.1007/s11682-013-9251-2.
2
Detection and application of neurochemical profile by multiple regional H-MRS in Parkinson's disease.通过多区域 H-MRS 检测和应用神经化学谱在帕金森病中的研究。
Brain Behav. 2017 Aug 13;7(9):e00792. doi: 10.1002/brb3.792. eCollection 2017 Sep.
3
Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods.帕金森病:6-羟基多巴胺处理的大鼠在不同时期额叶和顶叶皮质的体内代谢变化。
Int J Neurosci. 2014 Feb;124(2):125-32. doi: 10.3109/00207454.2013.825616. Epub 2013 Aug 15.
4
Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy.丘脑切开术后帕金森病的质子磁共振波谱变化
Eur J Radiol. 2003 Sep;47(3):179-87. doi: 10.1016/s0720-048x(02)00211-5.
5
Evaluation of the Braak staging of brain pathology with H-MRS in patients with Parkinson's disease.帕金森病患者脑病理Braak分期的氢质子磁共振波谱评估
Neurosci Lett. 2017 Nov 1;660:57-62. doi: 10.1016/j.neulet.2017.08.050. Epub 2017 Aug 24.
6
Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.多巴胺能治疗后新发帕金森病的代谢变化:一项质子磁共振波谱研究。
Neurosci Lett. 2015 Jul 10;599:55-60. doi: 10.1016/j.neulet.2015.05.044. Epub 2015 May 22.
7
Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.丘脑切开术后帕金森病的代谢改变:1H磁共振波谱分析结果
Korean J Radiol. 2002 Jul-Sep;3(3):180-8. doi: 10.3348/kjr.2002.3.3.180.
8
Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment.帕金森病轻度认知障碍患者中明显的 N-乙酰天门冬氨酸和胆碱代谢物变化。
Parkinsonism Relat Disord. 2013 Mar;19(3):329-34. doi: 10.1016/j.parkreldis.2012.11.012. Epub 2012 Dec 11.
9
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.在临床环境中,后扣带回皮质中的代谢物比率与帕金森病的认知衰退无关。
Parkinsonism Relat Disord. 2016 Jan;22:54-61. doi: 10.1016/j.parkreldis.2015.11.008. Epub 2015 Nov 12.
10
Proton MR Spectroscopy for Monitoring Pathologic Changes in the Substantia Nigra and Globus Pallidus in Parkinson Disease.质子磁共振波谱在帕金森病黑质和苍白球病理变化监测中的应用。
AJR Am J Roentgenol. 2016 Feb;206(2):385-9. doi: 10.2214/AJR.14.14052.

引用本文的文献

1
Brain proton magnetic resonance spectroscopy in patients with Parkinson's disease.帕金森病患者的脑质子磁共振波谱分析
Curr J Neurol. 2022 Jul 6;21(3):156-161. doi: 10.18502/cjn.v21i3.11108.
2
Proton Magnetic Resonance Spectroscopy for the Early Diagnosis of Parkinson Disease in the Substantia Nigra and Globus Pallidus: A Meta-Analysis With Trial Sequential Analysis.质子磁共振波谱在黑质和苍白球中早期诊断帕金森病的研究:一项采用序贯试验分析的Meta分析
Front Neurol. 2022 Jun 16;13:838230. doi: 10.3389/fneur.2022.838230. eCollection 2022.
3
Effect of MAO-B Inhibitors on Neurometabolic Profile of Patients Affected by Parkinson Disease: A Proton Magnetic Resonance Spectroscopy Study.
单胺氧化酶B抑制剂对帕金森病患者神经代谢特征的影响:一项质子磁共振波谱研究
J Clin Med. 2022 Mar 30;11(7):1931. doi: 10.3390/jcm11071931.
4
Magnetic resonance spectroscopy across chronic pain disorders: a systematic review protocol synthesising anatomical and metabolite findings in chronic pain patients.磁共振波谱在慢性疼痛障碍中的应用:一项系统综述方案,旨在综合慢性疼痛患者的解剖和代谢物研究结果。
Syst Rev. 2019 Dec 27;8(1):338. doi: 10.1186/s13643-019-1256-5.
5
Altered Neurometabolic Profile in Early Parkinson's Disease: A Study With Short Echo-Time Whole Brain MR Spectroscopic Imaging.早期帕金森病的神经代谢特征改变:一项采用短回波时间全脑磁共振波谱成像的研究。
Front Neurol. 2019 Jul 17;10:777. doi: 10.3389/fneur.2019.00777. eCollection 2019.
6
A comprehensive regional neurochemical theory in depression: a protocol for the systematic review and meta-analysis of 1H-MRS studies in major depressive disorder.全面区域性神经化学理论在抑郁症中的应用:一项对重性抑郁障碍 1H-MRS 研究进行系统回顾和荟萃分析的方案。
Syst Rev. 2018 Oct 12;7(1):158. doi: 10.1186/s13643-018-0830-6.
7
Metabolic Disturbances in the Striatum and Substantia Nigra in the Onset and Progression of MPTP-Induced Parkinsonism Model.MPTP诱导的帕金森病模型发病及进展过程中纹状体和黑质的代谢紊乱
Front Neurosci. 2018 Feb 20;12:90. doi: 10.3389/fnins.2018.00090. eCollection 2018.
8
Chemical Exchange Saturation Transfer MRI Signal Loss of the Substantia Nigra as an Imaging Biomarker to Evaluate the Diagnosis and Severity of Parkinson's Disease.黑质化学交换饱和转移磁共振成像信号丢失作为评估帕金森病诊断和严重程度的成像生物标志物
Front Neurosci. 2017 Aug 31;11:489. doi: 10.3389/fnins.2017.00489. eCollection 2017.
9
Altered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's Disease.帕金森病中纹状体小脑代谢改变与全身炎症
Oxid Med Cell Longev. 2016;2016:1810289. doi: 10.1155/2016/1810289. Epub 2016 Sep 1.
10
Magnetic Resonance Techniques Applied to the Diagnosis and Treatment of Parkinson's Disease.应用于帕金森病诊断与治疗的磁共振技术
Front Neurol. 2015 Jul 3;6:146. doi: 10.3389/fneur.2015.00146. eCollection 2015.